Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) is reporting second quarter financial results on Tuesday 4th August 2020, after market close.
According to analysts surveyed by Thomson Reuters, TRHC is expected to report 2Q20 income of $ 0.06 per share from revenue of $ 78.09 million.
For the full year, analysts anticipate top line of $ 333.32 million, while looking forward to income of $ 0.76 per share bottom line.
The Company Outlook
Revenue for 2Q20 are expected in a range of $ 76.00 million ~ $ 81.00 million
Full Year 2020 topline are forecasted in a range of$ 332.00 million ~ $ 352.00 million
Click Here For More Historical Outlooks Of Tabula Rasa HealthCare, Inc.
Previous Quarter Performance
Tabula Rasa HealthCare, Inc. announced income for the first quarter of $ 0.01 per share, from the revenue of $ 72.83 million. The quarterly earnings declined 90.00 percent while revenues extended 19.47 percent compared with the same quarter last year. Street analysts expected $ 71.64 million. The top line results outshined analysts by $ 1.19 million or 1.66 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Tabula Rasa HealthCare, Inc.
Stock Performance
According to the previous trading day, closing price of TRHC was $ 55.73, representing a 68.67 % increase from the 52 week low of $ 33.04 and a 20.07 % decrease over the 52 week high of $ 69.72.
The company has a market capital of $ 1.28 billion and is part of the Technology sector and Health Information Services industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”TRHC” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the field of medication safety in the United States. The companys proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks.
